ASX 200 down 0.1%: Kogan crashes, AMP's demerger plans, Telstra strengthens 5G network

AMP Ltd (ASX:AMP) and Kogan.com Ltd (ASX:KGN) shares are making waves on the ASX 200 on Friday. Here's what you need to know…

At lunch on Friday the S&P/ASX 200 Index (ASX: XJO) is on course to have a subdued finish to the week. The benchmark index is currently down 0.1% to 7,046 points.

Here's what is happening on the market today:

Worried young male investor watches financial charts on computer screen

Image source: Getty Images

Kogan update disappoints

The Kogan.com Ltd (ASX: KGN) share price has been sold off today after the release of a disappointing third quarter update. Although the ecommerce company reported a 47% increase in gross sales and a 54% jump in gross profit, its operating earnings actually declined by 24%. The damage was done primarily in the core Kogan business, which reported a 42% decline in adjusted operating earnings. This was driven by a significant increase in operating costs.

AMP announces demerger plans

The AMP Ltd (ASX: AMP) share price is pushing higher today after announcing demerger plans. According to the release, the company intends to pursue a demerger of AMP Capital's Private Markets business. Management believes the demerger will create two focused businesses, better equipped to pursue and allocate capital to distinct growth opportunities and realise efficiencies.

Telstra buys more 5G spectrum

The Telstra Corporation Ltd (ASX: TLS) share price is trading largely flat today after announcing a $277 million investment in the 26 GHz spectrum auction. According to the release, the telco giant has secured 1000 MHz of additional spectrum. It expects this to further extend its leadership in 5G now and into the future. Telstra advised that it secured the spectrum in all major capital cities and regional areas where it was sold.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Friday has been the Nuix Ltd (ASX: NXL) share price. It is up a decent 6.5% at lunch. This morning Morgan Stanley retained its overweight rating but trimmed its price target to $7.50. The worst performer has been the Kogan share price with an 11% decline following its third quarter update.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Nuix Pty Ltd. The Motley Fool Australia owns shares of and has recommended Kogan.com ltd and Telstra Limited. The Motley Fool Australia has recommended Nuix Pty Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Opinions

These are the best 3 ASX growth shares I own and I'd buy more of today

I’m bullish about the earnings potential of these three ASX growth shares.

Read more »